1.Neuroleptic malignant syndrome.
Journal of Korean Neuropsychiatric Association 1993;32(4):472-483
No abstract available.
Neuroleptic Malignant Syndrome*
2.Bloodstream infections caused by resistant bacteria in surgical patients admitted to Modilon Hospital, Madang.
Asa, Henao ; Laman, Moses ; Greenhill, Andrew R ; Siba, Peter M ; Davis, Timothy M E ; Maihua, John ; Manning, Laurens
Papua and New Guinea medical journal 2012;55(1-4):5-11
In view of the dearth of information relating to antibiotic resistance in community- and hospital-acquired bacterial infections in Papua New Guinea (PNG), we carried out a prospective, hospital-based observational study of surgical patients between October 2008 and October 2009. In a sample of 115 patients (median age 30 years; 55% males) suspected of having a bloodstream infection, blood cultures were positive in 11 (10%) and a significant pathogen was isolated in 9 (8%). Staphylococcus aureus was isolated in 4 patients (44%) and 3 were methicillin resistant; all these isolates were considered community acquired because cultures were performed within 48 hours of admission. Of the remaining 5 isolates, 4 were Gram-negative organisms with at least intermediate resistance to chloramphenicol that were grown from blood taken > 48 hours post-admission and thus considered nosocomially acquired. These data suggest two distinct patterns of bacterial infection in PNG surgical inpatients that have implications for national antibiotic prescription guidelines.
3.How the Commonwealth of the Northern Mariana Islands stalled COVID-19 for 22 months and managed its first significant community transmission
Dwayne Davis ; Stephanie Kern-Allely ; Lily Muldoon ; John M Tudela ; Jesse Tudela ; Renea Raho ; Heather S Pangelinan ; Halina Palacios ; John Tabaguel ; Alan Hinson ; Guillermo Lifoifoi ; Warren Villagomez ; Joseph R Fauver ; Haley L Cash ; Esther Muñ ; a ; Sean T Casey ; Ali S Khan
Western Pacific Surveillance and Response 2023;14(1):76-85
Objective: The Commonwealth of the Northern Mariana Islands (CNMI) is a remote Pacific island territory with a population of 47 329 that successfully prevented the significant introduction of coronavirus disease (COVID-19) until late 2021. This study documents how the response to the introduction of COVID-19 in CNMI in 2021 was conducted with limited resources without overwhelming local clinical capacity or compromising health service delivery for the population.
Methods: Data from COVID-19 case investigations, contact tracing, the Commonwealth’s immunization registry and whole genome sequencing were collated and analysed as part of this study.
Results: Between 26 March 2020 and 31 December 2021, 3281 cases and 14 deaths due to COVID-19 were reported in CNMI (case fatality rate, 0.4%). While notification rates were highest among younger age groups, hospitalization and mortality rates were disproportionately greater among those aged >50 years and among the unvaccinated. The first widespread community transmission in CNMI was detected in October 2021, with genomic epidemiology and contact tracing data indicating a single introduction event involving the AY.25 lineage and subsequent rapid community spread. Vaccination coverage was high before widespread transmission occurred in October 2021 and increased further over the study period.
Discussion: Robust preparedness and strong leadership generated resilience within the public health sector such that COVID-19 did not overwhelm CNMI’s health system as it did in other jurisdictions and countries around the world. At no point was hospital capacity exceeded, and all patients received adequate care without the need for health-care rationing.